Inflammation in Atherosclerosis: Transition From Theory to Practice

1. Libby P. Atherosclerosis: The new view. Sci Am 2002; 286: 46-55.

10.1038/nature01323

10.1161/hc0902.104353

4. Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 2008; 18: 228-232.

5. Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008; 451: 904-913.

10.1126/science.1990440

7. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. Inducible expression of vascular cell adhesion molecule-1 (VCAM-1) by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol 1993; 143: 1551-1559.

10.1016/S1097-2765(00)80139-2

10.1038/29788

10. Clinton S, Underwood R, Sherman M, Kufe D, Libby P. Macrophage-colony stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992; 140: 301-316.

11. Rosenfeld M, Ylä-Herttuala S, Lipton B, Ord V, Witztum J, Steinberg D. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol 1992; 140: 291-300.

10.1172/JCI28549

10.1161/CIRCULATIONAHA.108.783068

10.1172/JCI29950

10.1161/CIRCULATIONAHA.108.771048

10.1038/nri1882

10.1056/NEJMra043430

18. Schulte S, Sukhova GK, Libby P. Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. Am J Pathol 2008; 172: 1500-1508.

10.1161/01.ATV.0000259365.31469.89

20. Han SF, Liu P, Zhang W, Bu L, Shen M, Li H, et al. The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin Immunol 2007; 124: 90-97.

21. Binder CJ, Horkko S, Dewan A, Chang MK, Kieu EP, Goodyear CS, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: Molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003; 9: 736-743.

10.1253/circj.CJ-08-0733

10.1253/circj.CJ-08-0968

10.1172/JCI6993

25. Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, et al. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 2006; 113: 2301-2312.

26. van Wanrooij EJ, de Jager SC, van Es T, de Vos P, Birch HL, Owen DA, et al. CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28: 251-257.

27. Mach F, Schoenbeck U, Bonnefoy JY, Pober J, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor. Circulation 1997; 96: 396-399.

10.1073/pnas.94.5.1931

29. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate intersitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1991; 11: 1223-1230.

10.1001/jama.291.23.2847

10.1253/circj.70.1525

10.1253/circj.71.1332

10.1016/S0378-1119(96)00730-5

34. Rocha VZ, Libby P. The multiple facets of the fat tissue. Thyroid 2008; 18: 175-183.

35. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation [Review]. N Engl J Med 1999; 340: 448-454 [published erratum appears in N Engl J Med 1999; 340: 1376].

10.1016/S0021-9150(99)00463-3

37. Libby P, Ridker PM. Novel inflammatory markers of coronary risk: Theory versus practice. Circulation 1999; 100: 1148-1150.

38. Lemieux I, Pascot A, Prud'homme D, Almeras N, Bogaty P, Nadeau A, et al. Elevated C-reactive protein: Another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001; 21: 961-967.

39. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.

10.1172/JCI200319451

41. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, Perrard JL, et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007; 115: 1029-1038.

42. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, et al. T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008; 28: 1304-1310.

43. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, et al. Lean, but not obese, fat is enriched for a unique population of regulator T cells that affect metabolic parameters. Nat Med 2009; 15: 930-939.

44. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920.

45. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: A role for adaptive immunity in obesity. Circ Res 2008; 103: 467-476.

10.1074/jbc.271.18.10697

10.1074/jbc.270.45.26746

10.1006/bbrc.1996.0587

49. Shibata R, Ouchi N, Murohara T. Adiponectin and cardiovascular disease. Circ J 2009; 73: 608-614.

10.1006/bbrc.1999.0255

10.1042/CS20050182

10.1161/CIRCRESAHA.107.164988

10.1056/NEJM200106283442601

54. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Engl J Med 2008; 359: 2195-2207.

55. Glynn RJ, Danielson E, Fonseca FAH, Genest J, Gotto AM Jr, Kastelein JJP, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism: The JUPITER Trial. N Engl J Med 2009; 360: 1851-1861.